GO Term | Evidence Code | PMID |
---|---|---|
positive regulation of acute inflammatory response | ||
T cell chemotaxis |
|
|
phosphatidylinositol-mediated signaling | ||
negative regulation of cardiac muscle contraction |
|
|
hepatocyte apoptotic process |
GO Term | Evidence Code | PMID |
---|---|---|
kinase activity | ||
ephrin receptor binding | ||
1-phosphatidylinositol-3-kinase activity | ||
protein serine/threonine kinase activity | ||
protein serine kinase activity |
DO ID | Disease Name | Source |
---|---|---|
DOID:4783 | mesangial proliferative glomerulonephritis | |
DOID:4790 | medulloepithelioma | |
DOID:4791 | supratentorial primitive neuroectodermal tumor | |
DOID:4794 | obsolete embryonal Tumor with Multilayered Rosettes, C19MC-Altered | |
DOID:483 | cavernous hemangioma | |
DOID:4840 | sebaceous carcinoma | |
DOID:4844 | benign ependymoma | |
DOID:4851 | pilocytic astrocytoma | |
DOID:4866 | salivary gland adenoid cystic carcinoma | |
DOID:4896 | bile duct adenocarcinoma |
HPO ID | HPO Term |
---|---|
HP:0000007 | Autosomal recessive inheritance |
HP:0000010 | Recurrent urinary tract infections |
HP:0000403 | Recurrent otitis media |
HP:0000964 | Eczematoid dermatitis |
HP:0001252 | Hypotonia |
HP:0001433 | Hepatosplenomegaly |
HP:0001581 | Recurrent skin infections |
HP:0001742 | Nasal congestion |
HP:0001744 | Splenomegaly |
HP:0001873 | Thrombocytopenia |
Disease ID | Disease Name |
---|---|
OMIM:619802 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
115036690 | ECHNA41811 | ||
115403926 | SALFA10000 | ||
113490925 | ATHCN05581 | ||
105815179 | PROCO05914 | ||
109060929 | CYPCA63285 | ||
109064199 | CYPCA33330 | ||
103732179 | NANGA02072 | ||
116442892 | CORMO19998 | ||
103252973 | CARSF17749 | ||
115605592 | STRHB21515 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024